American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Clene Inc. (CLNN)

$3.88 +0.00% NASDAQ: CLNN · 15-min delayed

SALT LAKE CITY, Utah
Public · NASDAQ: CLNN
79 employees

Visit website Follow

$68.9MMarket cap

$200.0KRevenue · FY2025

-$26.2MNet income

79Employees

CLNNNASDAQ

2020IPO

About Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: CLNN
Employees: 79
IPO date: Dec 31, 2020
Headquarters: 6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, Utah 84121
Phone: 801-676-9695
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: CLNN Nasdaq
SEC CIK: 1822791
EIN: 852828339
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Clene Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/clene-inc/"><img src="https://americancompanies.com/badge/clene-inc.svg" alt="Clene Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Clene Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $200.0K
Net income: -$26.2M
Total assets: $18.1M
Market cap: $68.9M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: CLNN

$3.88 +0.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.10 $12.50

52-week range

Market cap: $68.9M
Shares outstanding: 17.8M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Dec 31, 2020

Clene Inc. (CLNN) Stock Price

Reported a net loss of $26.2M in FY2025.
Trading 69% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Clene Inc..

Write a review

Newsroom

News about Clene Inc.

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS GlobeNewswire Inc. · 2026-10-19 · positive Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts GlobeNewswire Inc. · 2026-02-24 · positive Clene to Provide CNM-Au8® ALS Program Update GlobeNewswire Inc. · 2025-12-02 · neutral Clene Posts 70% Revenue Drop in Q2 The Motley Fool · 2025-08-14 · neutral Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference GlobeNewswire Inc. · 2024-09-03 · positive Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire GlobeNewswire Inc. · 2024-07-17 · positive

News & sentiment via Polygon.io

FAQ

Clene Inc.: frequently asked questions

Is Clene Inc. an American company?

Clene Inc. is a US-based company headquartered in Salt Lake City, Utah, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Clene Inc. headquartered?

Clene Inc. is headquartered in Salt Lake City, Utah, United States.

Is Clene Inc. publicly traded?

Yes — Clene Inc. is a publicly traded company. Its stock trades under the ticker symbol CLNN on the NASDAQ.

What does Clene Inc. do?

Clene Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore